Jakub Gemperle

Jakub Gemperle

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2013 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
RJRadoslav Janostiak
Radoslav Janostiak
JBJan Brábek
Jan Brábek
VAVera Auernheimer
Vera Auernheimer
ZTZuzana Tatárová
Zuzana Tatárová
LLLena A. Lautscham
Lena A. Lautscham
DRDaniel Rosel
Daniel Rosel
Focal adhesions are cellular structures through which both mechanical forces and regulatory signals are transmitted. Two focal adhesion-associated proteins, Crk-associated substrate (CAS) and vinculin, were both independently shown to be crucial for the ability of cells to transmit mechanical forces and to regulate cytoskeletal tension. Here, we identify a novel, direct binding interaction between CAS and vinculin. This interaction is mediated by the CAS SRC homology 3 domain and a proline-rich sequence in the hinge region of vinculin. We show that CAS localization in focal adhesions is partially dependent on vinculin, and that CAS–vinculin coupling is required for stretch-induced activation of CAS at the Y410 phosphorylation site. Moreover, CAS–vinculin binding significantly affects the dynamics of CAS and vinculin within focal adhesions as well as the size of focal adhesions. Finally, disruption of CAS binding to vinculin reduces cell stiffness and traction force generation. Taken together, these findings strongly implicate a crucial role of CAS–vinculin interaction in mechanosensing and focal adhesion dynamics.

1 February 2019 in Cell Chemical Biology
Verified
Journal Article
Closed access
LKLenka Koudelková
Lenka Koudelková
APAndreea Csilla Pataki
Andreea Csilla Pataki
OTOndřej Tolde
Ondřej Tolde
VPVojtěch Pavlík
Vojtěch Pavlík
Max NobisMax Nobis
Max Nobis
DRDaniel Rosel
Daniel Rosel

13 November 2018 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
JGJakub Gemperle
Jakub Gemperle
MDMichal Dibus
Michal Dibus
LKLenka Koudelková
Lenka Koudelková
DRDaniel Rosel
Daniel Rosel
JBJan Brábek
Jan Brábek
Protein p130Cas constitutes an adaptor protein mainly involved in integrin signaling downstream of Src kinase. Owing to its modular structure, p130Cas acts as a general regulator of cancer cell growth and invasiveness induced by different oncogenes. However, other mechanisms of p130Cas signaling leading to malignant progression are poorly understood. Here, we show a novel interaction of p130Cas with Ser/Thr kinase PKN3, which is implicated in prostate and breast cancer growth downstream of phosphoinositide 3‐kinase. This direct interaction is mediated by the p130Cas SH3 domain and the centrally located PKN3 polyproline sequence. PKN3 is the first identified Ser/Thr kinase to bind and phosphorylate p130Cas and to colocalize with p130Cas in cell structures that have a pro‐invasive function. Moreover, the PKN3–p130Cas interaction is important for mouse embryonic fibroblast growth and invasiveness independent of Src transformation, indicating a mechanism distinct from that previously characterized for p130Cas. Together, our results suggest that the PKN3–p130Cas complex represents an attractive therapeutic target in late‐stage malignancies.

14 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JGJakub Gemperle
Jakub Gemperle
RHRozálie Hexnerová
Rozálie Hexnerová
MLMartin Lepšík
Martin Lepšík
PTPetr Tesina
Petr Tesina
MDMichal Dibus
Michal Dibus
DRDaniel Rosel
Daniel Rosel
CAS is a docking protein downstream of the proto-oncogene Src with a role in invasion and metastasis of cancer cells. The CAS SH3 domain is indispensable for CAS-mediated signaling, but structural aspects of CAS SH3 ligand binding and regulation are not well understood. Here, we identified the consensus CAS SH3 binding motif and structurally characterized the CAS SH3 domain in complex with ligand. We revealed the requirement for an uncommon centrally localized lysine residue at position +2 of CAS SH3 ligands and two rather dissimilar optional anchoring residues, leucine and arginine, at position +5. We further expanded the knowledge of CAS SH3 ligand binding regulation by manipulating tyrosine 12 phosphorylation and confirmed the negative role of this phosphorylation on CAS SH3 ligand binding. Finally, by exploiting the newly identified binding requirements of the CAS SH3 domain, we predicted and experimentally verified two novel CAS SH3 binding partners, DOK7 and GLIS2.

4 July 2025 in Science Advances
Verified
Journal Article
Open access
JGJakub Gemperle
Jakub Gemperle
DLDomenik Liße
Domenik Liße
MKMarie Kappen
Marie Kappen
ESEmilie Secret
Emilie Secret
MCMathieu COPPEY
Mathieu COPPEY
PCPatrick T Caswell
Patrick T Caswell
Endocytic recycling pathways play key roles in a broad range of cellular processes, and many vesicle trafficking regulators are implicated in progression of disease such as cancer. The Rab11 family (Rab11a, Rab11b, and Rab25) controls the return of internalized cargos to the plasma membrane, and Rab25 has been implicated in the aggressiveness of cancer by promoting invasive migration. However, while Rab25 vesicles distribute to the leading edge of moving cells, how directly they contribute to cell protrusion is not clear. Here, we adopt a magnetogenetic approach that allows direct manipulation of Rab25 positioning to show that localization to the cell periphery drives the formation of F-actin protrusions. We demonstrate that endogenous Rab25 vesicles coordinate the positioning of key cargos, including the actin regulator FMNL1 and integrin β1, with the activation of Rho guanosine triphosphatases at the plasma membrane to generate and maintain F-actin–rich filopodium-like protrusions and promote cancer cell invasive migration in the three-dimensional matrix.

1 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MKMarie Kappen
Marie Kappen
JGJakub Gemperle
Jakub Gemperle
ESEmilie Secret
Emilie Secret
JFJulia Flesch
Julia Flesch
PCPatrick T Caswell
Patrick T Caswell
JPJacob Piehler
Jacob Piehler
Remote control of cellular functions via magnetic forces offers unique opportunities in fundamental research and biomedical application. Intracellular delivery of functionalized magnetic nanoparticles (MNP) provides versatile opportunities to assemble signalling platforms for spatiotemporal control by magnetic forces. Such magnetogenetic application, however, has remained highly challenging due to a lack of MNP providing suitable biological, physicochemical and magnetic properties. Here, we achieved single-step surface coating of synthetic maghemite core nanoparticles with green fluo-rescent protein fused to the iron binding site of Mms6 from magnetotactic bacteria. We yielded MNP with intracellular stealth properties (syMagIcS), which could be readily biofunctionalized in situ and translocated within cells via magnetic field gradients. We successfully exploited syMagIcS for spati-otemporal control of Rac1 signalling at the plasma membrane via its guanine nucleotide exchange factor protein TIAM1 and for spatial control of liquid-liquid phase separation using the intrinsically disordered domain of the protein DDX4.